Z-1730-2023 Class I Ongoing

Recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-1730-2023 was initiated by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) on May 10, 2023 and is designated Class I. Reason for recall: There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy de… The recall status is ongoing. Affected quantity: 1 unit.

Recall Details

Product Type
Devices
Report Date
June 28, 2023
Initiation Date
May 10, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 unit

Product Description

CRT-D DTBA1D1G DF1 VIVA XT US GOLD CTD, Model Number DTBA1D1G; Implantable Cardioverter Defibrillators

Reason for Recall

There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

Distribution Pattern

US Nationwide - Worldwide Distribution

Code Information

GTIN 00643169956650, Lot Serial Numbers: BLF258300H